NEOP

(redirected from Neoprobe Corporation)
AcronymDefinition
NEOPNeoprobe Corporation (stock symbol)
NEOPNew Employee Orientation Program (various locations)
NEOPNear Earth Object Program
NEOPNew England Order of Protection
NEOPNuclear Explosive Operating Procedure
NEOPNuclear Energy of the Populace (Austria)
NEOPNo Expectation of Privacy (song)
References in periodicals archive ?
5 January 2012 - Neoprobe Corporation (NYSEAMEX:NEOP), a US-based biomedical company specialised in oncology products, said on Thursday that it has secured up to USD10m (EUR7.
Neoprobe Corporation (OTCBB: NEOP), Dublin, Ohio, a diversified developer of innovative oncology surgical and diagnostic products, has announced that it expects to report revenue of approximately $2.
Neoprobe Corporation (Nasdaq/NMS:NEOP), Dublin, Ohio, has signed an exclusive distribution agreement with Century Medical, Inc.
20 October 2011 - US Neoprobe Corporation (AMEX:NEOP) said yesterday that the US Food and Drug Administration (FDA) had accepted for review its New Drug Application (NDA) for Lymphoseek (tilmanocept).
AEP602) BRENT LARSON - NEOPROBE CORPORATION (NEOP).
8 September 2011 - US biomedical company Neoprobe Corporation (NYSE:NEOP) said yesterday that the European Medicines Agency (EMA) had issued a positive scientific advice on the development of RIGScan CR, the company's radiopharmaceutical for the detection of colorectal cancer.
11 August 2011 - US Neoprobe Corporation (NYSE: NEOP) said yesterday it has filed a New Drug Application (NDA) for Lymphoseek (tilmanocept) with the US Food and Drug Administration (FDA).
8 March 2011 - US oncology surgical and diagnostic products developer Neoprobe Corporation (AMEX: NEOP) said yesterday it has completed a successful pre-IND meeting with the US Food and Drug Administration (FDA) on the development of RIGScan CR, its radiopharmaceutical for the detection of colorectal cancer tumours.